BURGDORF LARS THORE,BEIER NORBERT,GLEITZ JOHANNES,CHARON CHRISTINE,CRAVO DANIEL,BURGDORF Lars Thore,BEIER Norbert,GLEITZ Johannes,CHARON Christine,CRAVO Daniel
申请号：
SI200830846
公开号：
SI2195312T1
申请日:
2008.08.13
申请国别(地区):
SI
年份:
2013
代理人:
摘要：
Novel heterocyclic compounds of the formula I in which R1, R2, R3, R4 and D have the meanings indicated in Claim 1, are activators of glucokinase and can be used for the prevention and/or treatment of Diabetes Typ 1 and 2, obesity, neuropathy and/or nephropathy.
